Immunophenotypic analysis and quantification of B-1 and B-2 B cells during human fetal hematopoietic development
Bueno, C, van Roon, E H J, Muñoz-López, A, Sanjuan-Pla, A, Juan, M, Navarro, A, Stam, R W, Menendez, P
Published in Leukemia (01.07.2016)
Published in Leukemia (01.07.2016)
Get full text
Journal Article
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
Garrido Castro, P, van Roon, E H J, Pinhanços, S S, Trentin, L, Schneider, P, Kerstjens, M, te Kronnie, G, Heidenreich, O, Pieters, R, Stam, R W
Published in Leukemia (01.02.2018)
Published in Leukemia (01.02.2018)
Get full text
Journal Article
Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants
Driessen, E. M. C., van Roon, E. H. J., Spijkers-Hagelstein, J. A. P., Schneider, P., de Lorenzo, P., Valsecchi, M. G., Pieters, R., Stam, R. W.
Published in Haematologica (Roma) (01.06.2013)
Published in Haematologica (Roma) (01.06.2013)
Get full text
Journal Article
The HDAC inhibitor panobinostat
Trentin, L, Stam, R W, te Kronnie, G, Garrido Castro, P, Heidenreich, O, Schneider, P, van Roon, E H J, Pinhanços, S S, Kerstjens, M, Pieters, R
Published in Leukemia (01.02.2018)
Get full text
Published in Leukemia (01.02.2018)
Journal Article